Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+55.6Cutaneous Melanoma+18.5Malignant Vulvar Neoplasm+18.5Malignant Laryngeal Neoplasm+14.8Malignant Vaginal Neoplasm+14.8Malignant Ovarian Neoplasm+14.8Malignant Bladder Neoplasm+11.2Malignant Pancreatic Neoplasm+7.4Malignant Kidney Neoplasm+3.7Malignant Thyroid Gland Neopl…+3.7Malignant Breast Neoplasm0Malignant Lung Neoplasm0Malignant Rectal Neoplasm0Malignant Salivary Gland Neop…-3.7Malignant Hypopharyngeal Neop…-3.7
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+55.6100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
22397
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
92.6
activityPercentile
37

ranking row 2595313

2=Cutaneous Melanoma+18.596.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3062
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
40.7
activityPercentile
22.2

ranking row 2595314

3=Malignant Vulvar Neoplasm+18.592.6Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
809
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
25.9
activityPercentile
7.4

ranking row 2595315

4=Malignant Laryngeal Neoplasm+14.888.9Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
814
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
29.6
activityPercentile
14.8

ranking row 2595316

4=Malignant Vaginal Neoplasm+14.888.9Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
382
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
14.8
activityPercentile
0

ranking row 2595317

6=Malignant Ovarian Neoplasm+14.881.5Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14787
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
85.2
activityPercentile
70.4

ranking row 2595318

7=Malignant Bladder Neoplasm+11.277.8Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4063
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
55.6
activityPercentile
44.4

ranking row 2595319

8=Malignant Pancreatic Neoplasm+7.474.1Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
16612
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
88.9
activityPercentile
81.5

ranking row 2595320

9=Malignant Kidney Neoplasm+3.770.4Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4734
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
59.3
activityPercentile
55.6

ranking row 2595321

9=Malignant Thyroid Gland Neoplasm+3.770.4Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
850
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
33.3
activityPercentile
29.6

ranking row 2595322

11=Malignant Breast Neoplasm063Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
41116
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
96.3
activityPercentile
96.3

ranking row 2595323

11=Malignant Lung Neoplasm063Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
69078
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2595324

11=Malignant Rectal Neoplasm063Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3827
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
48.1
activityPercentile
48.1

ranking row 2595325

14=Malignant Salivary Gland Neoplasm-3.751.9Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
238
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
7.4
activityPercentile
11.1

ranking row 2595326

15=Malignant Hypopharyngeal Neoplasm-3.748.1Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
58
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
0
activityPercentile
3.7

ranking row 2595327

16=Malignant Central Nervous System Neoplasm-3.744.4Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5835
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
74.1
activityPercentile
77.8

ranking row 2595328

16=Malignant Gastric Neoplasm-3.744.4Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4762
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
63
activityPercentile
66.7

ranking row 2595329

18=Multiple Myeloma-7.437Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5055
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
66.7
activityPercentile
74.1

ranking row 2595330

19=Malignant Cervical Neoplasm-7.433.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3924
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
51.9
activityPercentile
59.3

ranking row 2595332

19=Malignant Mesothelioma-7.433.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
535
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
18.5
activityPercentile
25.9

ranking row 2595331

21=Malignant Anal Neoplasm-7.425.9Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
369
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
11.1
activityPercentile
18.5

ranking row 2595333

22=Malignant Uterine Corpus Neoplasm-7.522.2Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3259
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
44.4
activityPercentile
51.9

ranking row 2595334

23=Non-Hodgkin Lymphoma-11.118.5Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9742
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
81.5
activityPercentile
92.6

ranking row 2595335

24=Hodgkin Lymphoma-11.114.8Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
588
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
22.2
activityPercentile
33.3

ranking row 2595336

25=Leukemia-11.111.1Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9443
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
77.8
activityPercentile
88.9

ranking row 2595337

26=Malignant Liver Neoplasm-14.87.4Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5527
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
70.4
activityPercentile
85.2

ranking row 2595338

27=Malignant Esophageal Neoplasm-263.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2888
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
37
activityPercentile
63

ranking row 2595339

28=Malignant Nasopharyngeal Neoplasm-370Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
186
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
3.7
activityPercentile
40.7

ranking row 2595340

Data updated 16 hours agoSource updated unknown28 eligible entities · inputs hash fd1e387680adb1d25b721db7